Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.23 -0.78%
EPS Growth %: -266.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -266.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $23.58 million.
Cash, cash equivalents and marketable securities was $851.5 million as of September 30, 2020.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Cosciens acquires Nualtis for up to $15M in cash deal
- Lightpath Technologies (LPTH) Misses Q4 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
